Virtus ETF Advisers’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,160
| Closed | -$301K | – | 276 |
|
|
2024
Q4 | $301K | Buy |
9,160
+2,118
| +30% | +$69.6K | 0.12% | 247 |
|
|
2024
Q3 | $313K | Hold |
7,042
| – | – | 0.15% | 227 |
|
|
2024
Q2 | $304K | Sell |
7,042
-9,353
| -57% | -$403K | 0.15% | 228 |
|
|
2024
Q1 | $479K | Buy |
16,395
+2,359
| +17% | +$69K | 0.25% | 181 |
|
|
2023
Q4 | $313K | Buy |
14,036
+2,213
| +19% | +$49.3K | 0.2% | 219 |
|
|
2023
Q3 | $293K | Sell |
11,823
-1,532
| -11% | -$37.9K | 0.18% | 203 |
|
|
2023
Q2 | $378K | Buy |
13,355
+3,423
| +34% | +$96.9K | 0.22% | 140 |
|
|
2023
Q1 | $228K | Buy |
9,932
+179
| +2% | +$4.11K | 0.13% | 297 |
|
|
2022
Q4 | $274K | Sell |
9,753
-4,050
| -29% | -$114K | 0.14% | 298 |
|
|
2022
Q3 | $390K | Buy |
13,803
+201
| +1% | +$5.68K | 0.16% | 233 |
|
|
2022
Q2 | $302K | Buy |
13,602
+2,061
| +18% | +$45.8K | 0.11% | 265 |
|
|
2022
Q1 | $336K | Hold |
11,541
| – | – | 0.15% | 165 |
|
|
2021
Q4 | $379K | Buy |
11,541
+3,692
| +47% | +$121K | 0.14% | 170 |
|
|
2021
Q3 | $362K | Sell |
7,849
-724
| -8% | -$33.4K | 0.16% | 183 |
|
|
2021
Q2 | $472K | Sell |
8,573
-9,755
| -53% | -$537K | 0.19% | 167 |
|
|
2021
Q1 | $946K | Buy |
18,328
+506
| +3% | +$26.1K | 0.4% | 94 |
|
|
2020
Q4 | $772K | Buy |
17,822
+5,424
| +44% | +$235K | 0.32% | 89 |
|
|
2020
Q3 | $434K | Buy |
12,398
+1,044
| +9% | +$36.5K | 0.23% | 153 |
|
|
2020
Q2 | $607K | Sell |
11,354
-1,246
| -10% | -$66.6K | 0.29% | 114 |
|
|
2020
Q1 | $447K | Sell |
12,600
-1,063
| -8% | -$37.7K | 0.18% | 182 |
|
|
2019
Q4 | $652K | Sell |
13,663
-755
| -5% | -$36K | 0.11% | 168 |
|
|
2019
Q3 | $467K | Sell |
14,418
-2,429
| -14% | -$78.7K | 0.09% | 184 |
|
|
2019
Q2 | $840K | Buy |
16,847
+2,307
| +16% | +$115K | 0.18% | 173 |
|
|
2019
Q1 | $981K | Buy |
14,540
+3,009
| +26% | +$203K | 2.09% | 9 |
|
|
2018
Q4 | $532K | Buy |
11,531
+3,316
| +40% | +$153K | 0.09% | 75 |
|
|
2018
Q3 | $634K | Buy |
8,215
+563
| +7% | +$43.5K | 0.07% | 91 |
|
|
2018
Q2 | $645K | Sell |
7,652
-6,753
| -47% | -$569K | 0.57% | 124 |
|
|
2018
Q1 | $1.18M | Buy |
14,405
+7,781
| +117% | +$636K | 1.02% | 22 |
|
|
2017
Q4 | $379K | Buy |
6,624
+189
| +3% | +$10.8K | 0.48% | 66 |
|
|
2017
Q3 | $430K | Buy |
6,435
+588
| +10% | +$39.3K | 0.06% | 102 |
|
|
2017
Q2 | $301K | Buy |
5,847
+578
| +11% | +$29.8K | 0.04% | 122 |
|
|
2017
Q1 | $308K | Buy |
5,269
+505
| +11% | +$29.5K | 0.05% | 132 |
|
|
2016
Q4 | $199K | Sell |
4,764
-304
| -6% | -$12.7K | 0.06% | 172 |
|
|
2016
Q3 | $268K | Hold |
5,068
| – | – | 0.13% | 115 |
|
|
2016
Q2 | $212K | Buy |
5,068
+114
| +2% | +$4.77K | 0.16% | 131 |
|
|
2016
Q1 | $201K | Buy |
+4,954
| New | +$201K | 0.28% | 82 |
|